Innovate CORP 8-K filings

R2 Technologies, a portfolio company of INNOVATE Corp., reports a 294% increase in Glacial Skin system sales and new partnerships with Woodhouse Spas and top skincare brands.

INNOVATE Corp. announced its third quarter 2024 results, showing a significant revenue decrease in its Infrastructure segment, but strong growth in Life Sciences and Spectrum.

INNOVATE Corp. has received notification from the New York Stock Exchange that it has regained compliance with the minimum average share price listing requirement.

Innovate Corp. has completed a 1-for-10 reverse stock split, effective August 8, 2024, to consolidate its outstanding shares.

INNOVATE Corp. announced its second quarter 2024 results, showing a decrease in overall revenue but significant improvements in net income and adjusted EBITDA, driven by strong performances in Infrastructure and Spectrum segments.

Innovate Corp. successfully amended its charter to increase authorized shares and provide officer exculpation, alongside other key approvals at its annual meeting.

INNOVATE Corp.'s virtual annual meeting of stockholders was adjourned due to technical difficulties and has been rescheduled for June 18, 2024.

INNOVATE Corp. announced its first quarter 2024 results, showing a slight decrease in revenue but a significant increase in adjusted EBITDA, driven by strong performances in its Infrastructure, Life Sciences, and Spectrum segments.

INNOVATE Corp. successfully closed its rights offering, issuing 5.3 million new common shares and 31.3 thousand preferred shares, raising a total of $35 million.

INNOVATE Corp. has announced the preliminary results of its rights offering, which, along with a concurrent private placement, is expected to generate approximately $35 million in gross proceeds.

INNOVATE Corp. has extended the expiration date of its $19 million common stock rights offering to April 19, 2024, providing additional time for eligible stockholders and noteholders to participate.

Innovate Corp. issued 25,000 shares of Series C Preferred Stock for $25 million to Lancer Capital, an investment fund led by the company's chairman, Avram A. Glazer.

Innovate Corp. has extended the expiration date of its $19 million common stock rights offering to April 9, 2024, to allow more time for eligible stockholders and noteholders to participate.

Innovate Corp. filed an amended auditor consent form to correct an omission of a registration statement reference in their previous filing.

INNOVATE Corp. has commenced a $19 million rights offering, allowing existing shareholders to purchase additional common stock.

INNOVATE Corp. has set the price for its rights offering at $0.70 per share, allowing existing shareholders to purchase additional shares.

INNOVATE Corp. announced its fourth quarter and full year 2023 results, showing a revenue decrease but highlighting progress in key strategic areas.

Innovate Corp. has been notified by the NYSE that it is not in compliance with listing standards due to its stock price falling below $1.00 for a sustained period.

INNOVATE Corp. has announced a $19 million rights offering for its common stock, with a backstop commitment from Lancer Capital.